Nicotinell Mint (Nicotine Lozenge)
Nicotine replacement therapy for smoking cessation and tobacco dependence
Nicotinell Mint is a nicotine replacement therapy (NRT) lozenge used to help people quit smoking or reduce their tobacco use. The lozenge contains nicotine that is slowly released and absorbed through the lining of the mouth, relieving withdrawal symptoms and cravings without the harmful chemicals found in cigarette smoke. It is available over-the-counter and is intended for adults aged 18 and older who are motivated to stop smoking.
Quick Facts
Key Takeaways
- Nicotinell Mint is an over-the-counter nicotine lozenge that helps relieve withdrawal symptoms and cravings when quitting smoking
- The 1 mg strength is recommended for light to moderate smokers; the 2 mg strength for heavier smokers
- Maximum daily dose is 24 lozenges (1 mg); treatment usually lasts 3–6 months with gradual dose reduction
- Can be combined with nicotine patches for heavily dependent smokers who have not succeeded with lozenges alone
- Keep out of reach of children — even small amounts of nicotine can cause serious harm or death in young children
What Is Nicotinell Mint and What Is It Used For?
Nicotinell Mint belongs to a group of medicines known as nicotine replacement therapies (NRTs). These products are designed to provide a controlled, lower dose of nicotine to the body without the thousands of harmful chemicals produced by burning tobacco. The active substance in Nicotinell Mint is nicotine, one of the principal addictive components found in tobacco products. When you suck on the lozenge, nicotine is slowly released and absorbed through the mucous membrane of the mouth (buccal mucosa).
The primary indication for Nicotinell Mint is to assist motivated smokers in their efforts to quit smoking entirely or to reduce their daily cigarette consumption as a step toward complete cessation. According to the World Health Organization (WHO), tobacco use kills more than 8 million people worldwide each year, with over 7 million of those deaths resulting from direct tobacco use and approximately 1.3 million from second-hand smoke exposure. Nicotine replacement therapy has been shown in Cochrane systematic reviews to increase the chances of successfully quitting by 50–60% compared to placebo.
The nicotine delivered by Nicotinell Mint lozenges works by reducing the intensity of nicotine withdrawal symptoms that occur when a person stops smoking. These symptoms can include irritability, difficulty concentrating, anxiety, restlessness, increased appetite, and strong cravings for a cigarette. By providing a small, controlled amount of nicotine, the lozenge helps bridge the gap between smoking and being entirely nicotine-free, making the transition more manageable.
Nicotinell Mint is intended for use by adults aged 18 years and older. It should not be used by non-smokers, as nicotine in any form can cause dependency and adverse effects in people who are not already tolerant to its pharmacological actions. Professional advice and behavioral support programs can significantly improve the chances of successfully quitting, and many healthcare guidelines recommend combining NRT with counseling for the best outcomes.
Smoking Cessation vs. Smoking Reduction
Nicotinell Mint can be used in two therapeutic strategies. The first approach is complete smoking cessation, where the person stops smoking entirely on their chosen quit date and uses the lozenges to manage withdrawal symptoms. The second approach is gradual smoking reduction, where lozenges are used between smoking periods to lengthen smoke-free intervals and progressively replace cigarettes. In either case, the goal is to eventually stop both smoking and lozenge use entirely.
What Should You Know Before Taking Nicotinell Mint?
Contraindications
Nicotinell Mint should not be used in the following situations:
- Allergy to nicotine or any of the other ingredients in the lozenge (see the Contents section for a full list)
- Non-smokers — people who have never used tobacco products should not use nicotine replacement therapy, as nicotine itself is an addictive substance and can cause adverse effects in non-tolerant individuals
Warnings and Precautions
Before using Nicotinell Mint, talk to your doctor or pharmacist if you have any of the following conditions, as special monitoring or dose adjustments may be required:
- Heart conditions — including recent heart attack (myocardial infarction), irregular heartbeat (arrhythmias), heart failure, or chest pain (angina pectoris, including Prinzmetal’s variant angina). If heart problems worsen during use, the dose must be reduced or treatment discontinued.
- History of stroke — either hemorrhagic (bleeding) or ischemic (blood clot) cerebrovascular events
- High blood pressure (hypertension) — nicotine can temporarily raise blood pressure and heart rate
- Circulatory problems — peripheral vascular disease or other disorders affecting blood flow
- Diabetes — blood glucose levels should be monitored more frequently when starting NRT, as your insulin or medication requirements may change when you stop smoking
- Overactive thyroid (hyperthyroidism) — nicotine can stimulate catecholamine release, potentially worsening thyroid-related symptoms
- Adrenal gland tumor (pheochromocytoma) — nicotine stimulates the adrenal glands and may trigger catecholamine surges
- Kidney or liver disease — impaired clearance of nicotine may lead to higher blood levels
- Esophagitis, gastritis, or peptic ulcers — nicotine can stimulate gastric acid secretion and worsen gastrointestinal conditions
- History of epilepsy (seizures) — nicotine may lower the seizure threshold in susceptible individuals
Nicotine doses that are tolerated by adult smokers can cause severe poisoning in small children and may be fatal. Always store Nicotinell Mint lozenges out of sight and reach of children. If a child accidentally swallows a lozenge, contact emergency services or a poison control center immediately.
Children and Adolescents
Nicotinell Mint should not be used by children under 12 years of age. Adolescents aged 12–17 years should only use this product on the advice and under the supervision of a healthcare professional. The developing brain is particularly sensitive to nicotine, and unsupervised use can establish or reinforce dependency patterns.
Pregnancy and Breastfeeding
Pregnancy: Quitting smoking during pregnancy is extremely important, as smoking is associated with restricted fetal growth, premature birth, and stillbirth. The ideal approach is to quit without using any nicotine-containing products. However, if you are unable to quit without pharmacological support, Nicotinell Mint should only be used after consulting a healthcare professional. The potential risks of continued smoking typically outweigh the risks associated with NRT use, but this assessment should be made on an individual basis.
Breastfeeding: Nicotinell Mint should be avoided during breastfeeding because nicotine passes into breast milk and can affect the nursing infant. If a healthcare provider recommends NRT during breastfeeding, the lozenge should be taken immediately after or at least two hours before nursing to minimize the amount of nicotine transferred to the infant.
Fertility: Smoking is known to impair fertility in both men and women. The specific effects of nicotine replacement therapy on fertility have not been extensively studied, but quitting smoking is expected to improve reproductive health outcomes overall.
Special Ingredients
Nicotinell Mint lozenges contain several inactive ingredients that may require attention in certain individuals:
- Aspartam (E951) — each lozenge contains 10 mg of aspartam, which is a source of phenylalanine. This may be harmful for people with phenylketonuria (PKU), a rare inherited metabolic disorder
- Maltitol (E965) — this is a sugar alcohol and a source of fructose. Contact your doctor before use if you have a hereditary fructose intolerance. Maltitol may have a mild laxative effect. Its caloric value is 2.3 kcal/g
- Sodium — the lozenge contains less than 1 mmol (23 mg) sodium per unit, making it essentially sodium-free
The ingredients are suitable for use by people with diabetes.
How Does Nicotinell Mint Interact with Other Drugs?
It is important to understand that it is primarily smoking cessation itself — rather than the nicotine lozenge — that causes clinically significant drug interactions. Cigarette smoke contains polycyclic aromatic hydrocarbons (PAHs) that are potent inducers of the cytochrome P450 enzyme CYP1A2 in the liver. When a person stops smoking, the activity of CYP1A2 decreases, which can lead to higher blood levels of medications metabolized by this enzyme. This change typically occurs within 1–2 weeks of complete smoking cessation.
Always inform your doctor or pharmacist if you are using other medications when starting smoking cessation therapy. Your healthcare provider may need to adjust your doses, particularly during the first few weeks after you stop smoking.
| Medication | Used For | Effect of Quitting Smoking | Action Required |
|---|---|---|---|
| Theophylline | Asthma, COPD | Blood levels may increase significantly | Monitor blood levels; dose reduction often needed |
| Clozapine | Schizophrenia | Blood levels may increase by 50–70% | Close monitoring; dose reduction may be necessary |
| Olanzapine | Schizophrenia, bipolar disorder | Blood levels may increase | Monitor for increased side effects; adjust dose |
| Tacrine | Alzheimer’s disease | Blood levels may increase | Monitor and adjust dose as needed |
| Insulin | Diabetes | Insulin sensitivity may change | Monitor blood glucose closely; adjust insulin dose |
| Warfarin | Blood clot prevention | INR may increase after smoking cessation | Monitor INR more frequently; adjust dose |
Food and Drink Interactions
Certain beverages can significantly reduce the absorption of nicotine from the lozenge. Coffee, acidic drinks (such as fruit juices), and carbonated beverages should be avoided for at least 15 minutes before using a Nicotinell Mint lozenge. These drinks lower the pH of the mouth, which reduces the ability of nicotine to cross the oral mucosa. Do not eat or drink anything while a lozenge is dissolving in your mouth.
What Is the Correct Dosage of Nicotinell Mint?
Always use Nicotinell Mint exactly as described in the package leaflet or as directed by your doctor or pharmacist. The lozenges are available in two strengths — 1 mg and 2 mg — and the choice of strength depends on the level of nicotine dependence.
Adults (18 Years and Older)
Choosing the Right Strength
The 1 mg lozenge is recommended for smokers with light to moderate nicotine dependence (typically those who smoke fewer than 20 cigarettes per day or who smoke their first cigarette more than 30 minutes after waking). The 2 mg lozenge is intended for smokers with moderate to strong dependence. If you experience side effects with the 2 mg strength, switch to the 1 mg dose.
Standard Dosing (Lozenge Alone)
Suck on one lozenge when you feel the urge to smoke. At the start of treatment, you may need one lozenge every 1–2 hours. Most people find 8–12 lozenges per day sufficient. The maximum daily dose is 24 lozenges of 1 mg. Do not use more than one lozenge per hour.
How to Use the Lozenge
- Place the lozenge in your mouth and suck on it until the taste becomes strong
- Rest the lozenge between your cheek and gum
- When the taste fades, begin sucking again
- Repeat this cycle until the lozenge has completely dissolved (approximately 30 minutes)
- Do not chew or swallow the lozenge
Treatment Duration for Complete Cessation
Treatment is individualized, but the typical course follows this pattern:
| Phase | Duration | Dosing |
|---|---|---|
| Initial Treatment | At least 3 months | 1 lozenge every 1–2 hours as needed (8–12/day typical) |
| Gradual Reduction | Weeks to months | Progressively reduce the number of lozenges per day |
| Discontinuation | When stable at low dose | Stop when down to 1–2 lozenges per day |
Treatment for longer than 6 months is generally not recommended, though some former smokers may require extended use to prevent relapse. If you are still using lozenges after 9 months, consult your doctor or pharmacist.
Combination Therapy with Nicotine Patches
For smokers with moderate to very strong dependence (typically smoking more than 20 cigarettes per day) who have not succeeded with lozenges alone, a combination of nicotine patches plus 1 mg lozenges may be used. This approach is strongly recommended to be undertaken with guidance from a healthcare professional.
| Phase | Patch | Lozenges |
|---|---|---|
| Initial (6–12 weeks) | 21 mg/24h patch | 5–6 per day as needed (max 15/day) |
| Step-down 1 (3–6 weeks) | 14 mg/24h patch | Continue as needed |
| Step-down 2 (3–6 weeks) | 7 mg/24h patch | Continue as needed |
| Final phase (up to 9 months total) | None | Gradually reduce and discontinue |
Gradual Smoking Reduction
For smokers not yet ready to quit completely, Nicotinell Mint can be used between smoking periods to lengthen smoke-free intervals. The number of cigarettes should be progressively replaced by lozenges. If you have not reduced your daily cigarette consumption by at least half after 6 weeks, seek professional advice. Aim to make a full quit attempt within 4 months of starting reduction therapy. Regular use beyond 6 months for reduction purposes is generally not recommended.
Missed Dose
Nicotinell Mint is used as needed rather than on a fixed schedule. There is no concern about “missing a dose” in the traditional sense. Simply use the next lozenge when you feel the urge to smoke. Do not use a double dose to compensate.
Overdose
Using too many lozenges can cause symptoms similar to excessive smoking: weakness, pale skin, sweating, excessive salivation, burning sensation in the throat, nausea, vomiting, diarrhea, abdominal pain, vision and hearing disturbances, headache, palpitations, dizziness, tremors, and confusion. In severe cases, these may progress to exhaustion, low blood pressure, circulatory collapse, respiratory failure, coma, and seizures.
If you suspect an overdose, or if a child has ingested lozenges, contact emergency services or a poison control center immediately. Even small amounts of nicotine can be dangerous and potentially fatal in children.
What Are the Side Effects of Nicotinell Mint?
Like all medicines, Nicotinell Mint can cause side effects, although not everyone experiences them. Many of the symptoms that appear during the first few days — such as dizziness, headache, and sleep difficulties — may actually be nicotine withdrawal symptoms related to smoking cessation rather than side effects of the lozenge itself. Other common withdrawal symptoms include insomnia, cough, fatigue, general malaise, and flu-like symptoms.
Swelling of the face, tongue, or throat; difficulty swallowing; hives (urticaria); or difficulty breathing. These may be signs of a serious allergic reaction (angioedema or anaphylaxis). These reactions are rare.
Very Common
May affect more than 1 in 10 people
- Nausea
Common
May affect up to 1 in 10 people
- Mouth inflammation and discomfort
- Sore throat
- Vomiting
- Stomach discomfort and pain
- Diarrhea
- Indigestion and heartburn
- Flatulence (gas)
- Hiccups
- Constipation
- Dizziness and headache
- Insomnia
- Cough
- Dry mouth
Uncommon
May affect up to 1 in 100 people
- Palpitations (awareness of heartbeat)
Rare
May affect up to 1 in 1,000 people
- Heart rhythm disturbances
- Allergic reactions and hypersensitivity
Additional Reported Effects (Frequency Not Known)
- Hives (urticaria)
- Ulcerative inflammation of the mouth
- Tremor
- Shortness of breath
- Difficulty swallowing
- Burping
- Increased saliva production
- Weakness and fatigue
- General malaise and flu-like symptoms
- Rapid or irregular heartbeat (atrial fibrillation)
Many gastrointestinal symptoms (such as heartburn and nausea) can be minimized by sucking the lozenge more slowly. If you swallow too much nicotine-containing saliva, it can irritate the stomach lining. Let the lozenge rest against your cheek and suck gently rather than aggressively.
Mouth ulcers may occur when quitting smoking, but the relationship to nicotine lozenge therapy specifically is unclear. If side effects persist or become bothersome, consult your doctor or pharmacist. You can also report suspected side effects to your national pharmacovigilance authority.
How Should You Store Nicotinell Mint?
Proper storage of Nicotinell Mint is essential both for maintaining the efficacy of the product and for safety. The following guidelines should be observed:
- Temperature: Store at or below 25°C (77°F). Do not expose to excessive heat or direct sunlight, as this may affect the stability of the nicotine content.
- Packaging: Keep the lozenges in the original blister packaging or container until ready to use. This protects them from moisture and light.
- Child safety: Store out of sight and reach of children at all times. Nicotine is toxic to children in small amounts.
- Expiry date: Do not use after the expiry date shown on the packaging (marked as “EXP”). The expiry date refers to the last day of the stated month.
- Disposal: Do not flush unused lozenges down the toilet or throw them in regular household waste. Return unused or expired lozenges to your pharmacy for safe disposal to protect the environment.
What Does Nicotinell Mint Contain?
Active Ingredient
Each Nicotinell Mint 1 mg lozenge contains 1 mg of nicotine (equivalent to 3.072 mg of nicotine bitartrate dihydrate). The bitartrate salt form ensures stable release characteristics and good absorption through the oral mucosa.
Inactive Ingredients (Excipients)
- Maltitol (E965) — sweetener and bulking agent
- Anhydrous sodium carbonate — pH adjuster to optimize nicotine absorption
- Sodium hydrogen carbonate — pH buffer
- Polyacrylate — binding agent
- Xanthan gum — thickener for controlled release
- Anhydrous colloidal silicon dioxide — flow agent
- Levomenthol — flavoring (mint)
- Peppermint oil — flavoring
- Aspartam (E951) — artificial sweetener (contains phenylalanine)
- Magnesium stearate — tablet lubricant
Physical Description
Nicotinell Mint is a white, round, biconvex lozenge with a mint flavor. It is available in blister packs (12, 36, 72, 96, 144, 192, or 204 lozenges) or in jars of 24 lozenges (packaged in cartons of 1, 3, 4, or 6 jars). Not all pack sizes may be available in every market.
Known Brand Alternatives
Other nicotine lozenge and oral NRT products available internationally include Nicotinell Spearmint, Nicorette Fruitmint, Nicotinell Tropical Fruit, NiQuitin Mint, Zonnic Mint, and Nicorette lozenges. While the active ingredient is the same, formulations, flavors, and excipients may vary between brands. Always follow the specific product instructions for the brand you are using.
Can You Drive While Using Nicotinell Mint?
When used according to the recommended dosing instructions, Nicotinell Mint is not expected to impair driving ability or the capacity to operate machinery. However, it is important to recognize that the process of quitting smoking can temporarily affect mood, concentration, and reaction times due to nicotine withdrawal. These changes are caused by the absence of smoking rather than by the lozenge itself. If you notice any effects that might impair your ability to drive safely, exercise caution until the symptoms resolve.
Frequently Asked Questions About Nicotinell Mint
Nicotinell Mint lozenges contain nicotine that is slowly released when you suck on the lozenge. The nicotine is absorbed through the lining of your mouth (buccal mucosa), providing a controlled dose that relieves withdrawal symptoms and cravings. Unlike cigarettes, the lozenge delivers nicotine without the harmful tar, carbon monoxide, and thousands of other toxic chemicals produced by combustion. Each lozenge takes approximately 30 minutes to dissolve completely.
The maximum daily dose is 24 lozenges of the 1 mg strength. Most people find 8–12 lozenges per day sufficient to manage cravings. Do not use more than 1 lozenge per hour. Start by using one lozenge every 1–2 hours when you feel the urge to smoke, then gradually reduce the number over the course of treatment (typically 3–6 months).
Quitting smoking during pregnancy is extremely important. Ideally, quit without using nicotine-containing products. If you cannot quit without pharmacological support, use Nicotinell Mint only after consulting your doctor or midwife. During breastfeeding, nicotine passes into breast milk — if NRT is necessary, take the lozenge immediately after or at least 2 hours before feeding.
Yes. Combination therapy with a nicotine patch (for a steady background level of nicotine) and a lozenge (for managing breakthrough cravings) is an evidence-based approach for heavily dependent smokers. This is typically recommended for those smoking more than 20 cigarettes per day. Start with a 21 mg/24h patch plus 5–6 lozenges (1 mg) per day, then step down over 3–9 months. Healthcare professional guidance is strongly recommended for combination therapy.
Avoid coffee, acidic drinks (fruit juices), and carbonated beverages for 15 minutes before using a lozenge, as these reduce nicotine absorption. Do not eat or drink while a lozenge is in your mouth. Most importantly, do not smoke while using nicotine replacement therapy, as this increases the risk of nicotine-related side effects and defeats the purpose of treatment.
If you have heart problems, consult your doctor before using Nicotinell Mint. While NRT is generally considered safer than continued smoking for people with cardiovascular disease, nicotine can raise heart rate and blood pressure. Your doctor will weigh the benefits of smoking cessation against any potential risks. If heart symptoms worsen during use, reduce the dose or stop and seek medical advice.
References
This article is based on internationally recognized medical guidelines and peer-reviewed research. All medical claims adhere to the GRADE evidence framework with Level 1A evidence (systematic reviews and meta-analyses of randomized controlled trials).
- World Health Organization (WHO). Tobacco Fact Sheet. Updated 2024. Available at: who.int/tobacco
- Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews. 2018;5:CD000146. doi:10.1002/14651858.CD000146.pub5
- European Medicines Agency (EMA). Summary of Product Characteristics — Nicotine-containing medicinal products for smoking cessation. 2024.
- National Institute for Health and Care Excellence (NICE). Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline NG209. Updated 2023.
- U.S. Food and Drug Administration (FDA). OTC Nicotine Replacement Therapy Products: Over-the-Counter Labeling. 2024.
- British National Formulary (BNF). Nicotine — Drug Monograph. Updated 2025. Available at: bnf.nice.org.uk
- Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews. 2013;5:CD009329.
- Benowitz NL. Nicotine addiction. New England Journal of Medicine. 2010;362(24):2295-2303.
Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, which consists of licensed physicians with expertise in addiction medicine, clinical pharmacology, and evidence-based medicine. All content follows the GRADE framework for evidence assessment and is reviewed according to guidelines from WHO, EMA, FDA, NICE, and BNF.
Content Development
Written by medical professionals with clinical experience in tobacco dependence treatment and pharmacotherapy.
Quality Assurance
Independently reviewed by the iMedic Medical Review Board. No pharmaceutical industry funding or influence.
Last medical review: | Next scheduled review: